INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
LY

Lin Elizabeth Yeu

Chief Medical OfficerCIK 0001842190

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 7
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,590 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Tarsus Pharmaceuticals, Inc.Chief Medical Officer · Mar 19, 2026
28
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL
$135K
1,590 sh
Sep 4, 2026
Sep 9, 2026
traded Sep 4, 2026
+5d
SEC FORM 4

Evidence

31
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$458K
5,387 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

35
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$485K
5,386 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$26K
390 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC FORM 4

Evidence

36
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$26K
375 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$26K
379 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence